Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
81 results
Topics : Blood and lymphatic diseases
Topics : Hematologic cancers
Language : Français
OK
Chercher
Filter
Topic
Diagnostic and therapeutic techniques
(81)
Plus ...
Drug therapy
(78)
Transfusions, transplantations
(8)
Diagnostic techniques and procedures
(4)
Plus ...
Biology (laboratory tests)
(4)
Cell and tissue pathology
(2)
Diseases and conditions
(81)
Plus ...
Blood and lymphatic diseases
(81)
Plus ...
Hematologic cancers
(81)
Bone marrow diseases
(4)
Blood and lymphatic diseases - miscellaneous
(3)
Blood coagulation and hemostasis disorders
(2)
Lymphatic diseases
(2)
Anemia and hemoglobinopathies
(2)
Congenital, genetic and rare diseases
(14)
Skin and connective tissue diseases
(13)
Plus ...
Skin and connective tissue cancers
(7)
Immune system diseases
(10)
Plus ...
Immunologic deficiency syndromes
(7)
Autoimmune diseases
(5)
Immune system diseases - miscellaneous
(3)
Infectious diseases
(7)
Plus ...
Virus diseases
(5)
Sexually transmitted diseases
(4)
Bacterial infections
(2)
Parasitic diseases and mycoses
(1)
Nervous system diseases
(6)
Plus ...
Demyelinating diseases
(4)
Nervous system diseases - miscellaneous
(2)
Neuromuscular diseases
(2)
Neurodegenerative diseases
(2)
Nervous system cancers
(2)
Cancers - miscellaneous
(5)
Urologic diseases
(4)
Plus ...
Urologic cancers
(3)
Kidney diseases
(1)
Digestive system diseases
(4)
Plus ...
Digestive system cancers
(4)
Musculoskeletal diseases
(4)
Plus ...
Bone cancers
(2)
Joint and rheumatic diseases
(1)
Muscle cancers
(1)
Respiratory tract diseases
(3)
Plus ...
Respiratory tract cancers
(3)
Breast diseases
(3)
Plus ...
Breast cancers
(3)
Genital diseases
(3)
Plus ...
Genital cancers
(3)
Female genital diseases
(1)
Vascular diseases
(3)
Plus ...
Vascular diseases - miscellaneous
(3)
Otorhinolaryngologic diseases
(1)
Plus ...
Otorhinolaryngologic cancers
(1)
Eye diseases
(1)
Plus ...
Eye cancers
(1)
Endocrine system and metabolic diseases
(1)
Plus ...
Endocrine gland cancers
(1)
Heart diseases
(1)
Plus ...
Heart abnormalities
(1)
Pain - Inflammation
(1)
Population groups
(23)
Plus ...
Paediatrics
(21)
Geriatrics
(3)
Economics and public health
(5)
Plus ...
Health economics
(4)
Screening, prevention
(1)
Content type
Drugs, devices and medical acts
(81)
Plus ...
Medicine
(77)
Health technology assessment
(4)
Date
Last five years
(30)
This year
(2)
Last three months
(2)
Manufacturer
industriels
(1)
Language
Français
(81)
Active substance
alcool
(1)
alemtuzumab
(1)
azacitidine
(1)
bendamustine ( chlorhydrate de )
(1)
busulfan
(2)
carmustine
(1)
chlorambucil
(1)
chlorhydrate de daunorubicine
(1)
cytarabine
(1)
dacarbazine
(2)
doxorubicine ( chlorhydrate de )
(1)
ganciclovir
(1)
idarubicine ( chlorhydrate d ' )
(1)
immunoglobuline humaine normale ( plasmatique )
(2)
lithium
(1)
nilotinib
(2)
ofatumumab
(1)
propranolol ( chlorhydrate de )
(1)
rituximab
(2)
temsirolimus
(1)
thalidomide
(1)
thymidine
(1)
tyrosine
(2)
voriconazole
(1)
More filter
Save your search
Search Export
Drugs, devices and medical acts
- 81 results
SARCLISA (isatuximab)
Medicine
- Posted on 31/10/2024
Add to
my selection
KEYTRUDA
Medicine
- Posted on 21/11/2024
Add to
my selection
Targeted next generation sequencing gene panel in the medical management of chronic lymphocytic leukemia Brief INAHTAhta
Health technology assessment
- Posted on 2/8/2024
Download
document
Add to
my selection
TEPKINLY (epcoritamab)
Medicine
- Posted on 20/3/2024
Add to
my selection
OLUTASIDENIB PHARMA BLUE
Medicine
- Posted on 18/10/2023
Add to
my selection
TIBSOVO (ivosidenib)
Medicine
- Posted on 18/6/2024
Add to
my selection
EMPLICITI (elotuzumab)
Medicine
- Posted on 20/1/2023
Add to
my selection
BREYANZI (lisocabtagene maraleucel)
Medicine
- Posted on 5/10/2023
Add to
my selection
METHOXSALENE MACOPHARMA (méthoxsalène)
Medicine
- Posted on 9/11/2023
Add to
my selection
SCEMBLIX (asciminib)
Medicine
- Posted on 5/7/2023
Add to
my selection
See 81 result in Drugs, devices and medical acts
Français
English
eNq1WF1v2jAUfedXICT2RkL4CmwJFaPQIrUbK6BNe0EmuUBYsFPbobBfPyehgnahTQ1+QAr+OPfa9+Tce2Ndbdd+fgOUeQTbBUMrF/KAHeJ6eGEXJuN+qVm4auesFdqgo2WmVtaMSiHv+IgxuxDNajNAmGm/7u+uQewHWmjn8haZrcDhL9aF3PO1W8SW9yiI1uStDfHc/Br4krh2IQh5PJq3GKfCi/YToX9YgByw9P3I8exqWjset/QILANqyIDeIbxIBQUshemElALmXcRhQeguFXruTCtNs9aqVKVMeOwBGAmpA0PEl0NKNp4Lbrol5DOQMjJ/ckdANz7wyEgquL5y1kwKHK3Q9gEeB+lOd8Rsl295qVwyzGq1YdYrplGrNaVM0aOrSiePOISeRKRumIYOWBd7Qp8jXnKhRMFZAhU/yVANCeXIVxQkj3Vf0k2RHQqP75LB9Vjgo522YoHsVSGKxDRQIQrqDhKdYEyFTPnizl7h49D39Q96PdmLiCKPI43qkhDzE1oyGcleRJdgDtvTEZWTP77dc9EDdjnYvwSnS/8wnPmeI6twQoNCYHzyMDgtcAq14StiMKHqxOGnh13yxC4vOsdBVuR9EOtmKmhAXWNaaTUbRr0u/U79Fow6kX96ISUB6EKOPHaOygzwnJyrL4Kk6VDPFFXFzrg2Ig7y4UR1VJJUHkHL52JOGfHVvVTJRCroTW8sy5YfIdDdKP6bCu259iHOcrqsQuwFOd/zPDJqf0Lr4AtfB3GCt/kuADYvVq+5ICgmPlkIFSlW+gvAQKOcrPU2yA8RF23GNbDx0aprGCFxjhiPBCNAgt4JeiIX9rE0xOP9Trc3no5ve/c925k2ao16TZiKn8wMK+Inw6gbjVY5Ix6FwBeu2sbxhrvOt5tp/Gj3Re1R7FaLHRN57IJLzudIcocZOpeq2WzJiQpNV/Ql5wH7rOtLxEosirA2p5mT79WBYyp49j/X3uJbNo58nHfZcV/xLyN7LrZMtqQ46JO6hlZJxZt0AEk5ocj1WVInZn91ZPPQe/XwuT3efv++l0xPGDSEM+KQlCzKCotB7/K1yqHBU+b28IWyqzMTN2OxoKrqCsLZG3lJOvOJwOI+FerwfT73TnxkPElMS08+cLZzlh593Gzn/gFaXPYk
qf4W9VvNskZPQQKC